Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 1 9Phase 3 8Phase NA 5Phase EARLY_PHASE1 5Phase 1/2 4

Status

Completed 23Recruiting 15Unknown 12Not yet recruiting 5Active not recruiting 5Terminated 3Withdrawn 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 324Gastrointestinal 244Genitourinary 185Thoracic 119Gynecologic 105Head & Neck 72CNS 63Tumor-Agnostic 61Lymphoid 58Other hematologic neoplasm 54Dermatologic 32Sarcoma 24Other 24Plasma cell 16Other solid neoplasm 16Endocrine 16Other neoplasm 7NET 5Myeloid 5Classical hematology 2

Conditions

Neuroendocrine Tumors 5Stomach Neoplasms 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1

Interventions

lutetium Lu 177 dotatate 1Surgical Procedures, Operative 1Poly(ADP-ribose) Polymerase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × NET × Clear all
NCT04804371 2026-03-23

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

University Health Network, Toronto

Phase NA Active not recruiting
40 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02743741 2025-12-03

Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors

University Health Network, Toronto

Phase NA Active not recruiting
195 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT06204159 2025-05-20

Trinav

Abramson Cancer Center at Penn Medicine

Phase NA Active not recruiting
12 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neuroendocrine Tumors

NCT04584008 2024-10-15

VISIONARY

Peking University

Phase NA Active not recruiting
600 enrolled
EndocrineGastrointestinalNETSarcoma

Esophageal Squamous Cell Carcinoma, Biliary Tract Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

NCT03012789 2024-04-30

NETest_Sx

Wren Laboratories LLC

Phase NA Active not recruiting
40 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡